Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2749628
Reference Type
Journal Article
Title
Pharmacokinetics of pramiracetam in healthy volunteers after oral administration
Author(s)
Auteri, A; Blardi, P; Celasco, G; Segre, G; Urso, R
Year
1992
Is Peer Reviewed?
Yes
Journal
International Journal of Clinical Pharmacology Research
ISSN:
0251-1649
Report Number
IPA/93/1028311
Volume
J
Issue
REF 6
Page Numbers
129-132
Language
English
Abstract
IPA COPYRIGHT: ASHP The pharmacokinetics of an oral solution and an oral tablet of 600 mg pramiracetam were studied in 11 healthy subjects (ages 18-74 yr). The mean half-life was 4.3 and 4.7 h, area under the concentration time curve was 57.6 and 47.2 mcg h/ml, and time to reach maximum concentration was 6.8 and 5.8 mcg/ml for the solution and tablet, respectively. The half-life was very variable between subjects, but less variable within subjects, and was unaffected by formulation. It was concluded that the pharmacokinetics of pramiracetam are not highly affected by the formulation except for the absorption rate, which is faster for the solution than for the tablet.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity